Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | KIT |
| Variant | T670E |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | KIT T670E lies within the protein kinase domain of the Kit protein (UniProt.org). T670E has been identified in sequencing studies (PMID: 25886408, PMID: 19834613, PMID: 35194937), but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Jul 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
KIT mutant KIT exon14 KIT T670X KIT T670E |
| Transcript | NM_000222.3 |
| gDNA | chr4:g.54729352_54729353delACinsGA |
| cDNA | c.2008_2009delACinsGA |
| Protein | p.T670E |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000222.2 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| XM_017008178.1 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| XM_017008178 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| NM_000222 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| NM_000222.3 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| NM_001385285.1 | chr4:g.54729352_54729353delACinsGA | c.2008_2009delACinsGA | p.T670E | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| KIT T670E | Advanced Solid Tumor | sensitive | Nintedanib | Preclinical - Cell culture | Actionable | In a preclinical study, Ofev (nintedanib) inhibited proliferation of transformed cells expressing KIT T670E in culture (PMID: 35194937). | 35194937 |
| KIT T670E | Advanced Solid Tumor | sensitive | Sunitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Sutent (sunitinib) inhibited proliferation of transformed cells expressing KIT T670E in culture (PMID: 35194937). | 35194937 |
| KIT T670E | Advanced Solid Tumor | resistant | Avapritinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT T670E demonstrated resistance to Ayvakit (avapritinib) in culture (PMID: 35194937). | 35194937 |
| KIT T670E | Advanced Solid Tumor | resistant | Ripretinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT T670E demonstrated resistance to Qinlock (ripretinib) in culture (PMID: 35194937). | 35194937 |
| KIT T670E | Advanced Solid Tumor | resistant | Imatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT T670E demonstrated resistance to Gleevec (imatinib) in culture (PMID: 35194937). | 35194937 |